Zanubrutinib

Zanubrutinib


Zanubrutinib (BGB-3111) is a potent, selective, and orally active covalent inhibitor of Bruton's tyrosine kinase (BTK), with an IC50 of 0.3 nM. It shows high selectivity for BTK over a panel of 304 kinases at 1?μM, although it also inhibits EGFR, Tec, Blk, BMX, HER4, and TXK (IC50s ranging from 0.62 to 33 nM). Zanubrutinib blocks BTK phosphorylation at Y223 (IC50 = 1.8 nM) in Ramos cells and reduces REC-1 cell viability (IC50 = 0.36 nM). In vivo, it decreases tumor volume in OCI-LY10 DLBCL xenograft models at doses of 2.5 and 7.5 mg/kg.

Molecular structure of the compound BP-44065
    • Unit
    • Price
    • Qty
    • 100 MG
    • $210.00
    • 250 MG
    • $320.00
    • 500 MG
    • $540.00
    • 1 G
    • $850.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire